Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Oncoimmunology|September 19, 2017
Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophagesKelly Kersten, Seth B Coffelt, Marlous Hoogstraat, et al.Genome Biology|April 19, 2015
CopywriteR: DNA copy number detection from off-target sequence dataThomas Kuilman, Arno Velds, Kristel Kemper, et al.Cell Reports|December 15, 2021
Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancerMark D Long, Justine J Jacobi, Prashant K Singh, et al.Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastasesFleur Weeber, Marc van de Wetering, Marlous Hoogstraat, et al.The Journal of Molecular Diagnostics : JMD|December 3, 2014
Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathologyMarlous Hoogstraat, John W J Hinrichs, Nicolle J M Besselink, et al.Plos One|September 18, 2014
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesCorine M Beaufort, Jean C A Helmijr, Anna M Piskorz, et al.Genome Biology|October 22, 2011
Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancerWigard P Kloosterman, Marlous Hoogstraat, Oscar Paling, et al.Pigment Cell & Melanoma Research|December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenibMarlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.Oncotarget|August 18, 2016
TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2Subramanian Venkatesan, Marlous Hoogstraat, Ester Caljouw, et al.The Journal of Allergy and Clinical Immunology|October 22, 2013
Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficienciesIsaac J Nijman, Joris M van Montfrans, Marlous Hoogstraat, et al.Pageof 4